Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering GMPs Linger: Whistleblower Suit Filed, Consent Decree Extended

Executive Summary

Schering-Plough has been named in a False Claims Act suit alleging the company (and two dozen other manufacturers) knowingly sold adulterated products to the federal government

You may also be interested in...



GSK Puerto Rico Plant Under Investigation By FDA; Received Warning In 2002

GlaxoSmithKline does not anticipate any immediate supply disruptions from an FDA investigation of its Cidra, Puerto Rico production facility

GSK Puerto Rico Plant Under Investigation By FDA; Received Warning In 2002

GlaxoSmithKline does not anticipate any immediate supply disruptions from an FDA investigation of its Cidra, Puerto Rico production facility

Schering/FDA Relations Are Priority For Hassan: GMPs, Asmanex On Agenda

Schering-Plough CEO Fred Hassan hopes his credibility with FDA can help in discussions over the company's GMP work plan and the delayed Asmanex approval

Related Content

UsernamePublicRestriction

Register

PS041828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel